Lantus, the first peakless basal insulin analogue: 10 years of clinical experience in children and adolescents
This review analyses existing literature, including authors' own data, describing the results of clinical trials which assess safety and efficacy of insulin Glargine (Lantus?) in children and adolescents, as well as peculiar features of T1D management in this age group, including the challenge...
Saved in:
Main Author: | |
---|---|
Format: | article |
Language: | EN RU |
Published: |
Endocrinology Research Centre
2014
|
Subjects: | |
Online Access: | https://doaj.org/article/947bfb4adf1b459f8c9e536232bf74b8 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!